{
  "metadata": {
    "id": "U4AOS2-04",
    "curriculum": "VCEAU",
    "subject": "biology",
    "unit": "U4",
    "aos": "AOS2",
    "topicCode": "04",
    "topicName": "Immunotherapy",
    "version": "1.0.0",
    "lastUpdated": "2026-01-08",
    "colorTheme": {
      "primary": "#10b981",
      "secondary": "#059669",
      "gradient": "linear-gradient(135deg, #10b981 0%, #059669 100%)"
    }
  },
  "tabs": [
    {
      "id": "overview",
      "label": "Overview",
      "icon": "therapy",
      "order": 1
    },
    {
      "id": "antibodies",
      "label": "Monoclonal Antibodies",
      "icon": "antibody",
      "order": 2
    },
    {
      "id": "cancer",
      "label": "Cancer Treatment",
      "icon": "target",
      "order": 3
    },
    {
      "id": "autoimmune",
      "label": "Autoimmune Treatment",
      "icon": "suppress",
      "order": 4
    }
  ],
  "concepts": {
    "immunotherapy_overview": {
      "formula": "Immunotherapy treats diseases by modulating the body's immune response, either activating or suppressing it",
      "correct": "Activation immunotherapies enhance immune responses; suppression immunotherapies reduce harmful immune activity",
      "wrong": [
        {
          "answer": "Immunotherapy replaces the immune system",
          "error": "Misunderstanding immunotherapy mechanism",
          "fix": "Immunotherapy modulates (enhances or suppresses) the existing immune system",
          "action": "Immunotherapy = modulate existing immunity, not replace it"
        },
        {
          "answer": "All immunotherapies activate the immune system",
          "error": "Ignoring suppression immunotherapies",
          "fix": "Some immunotherapies activate (for cancer); others suppress (for autoimmunity)",
          "action": "Activation = cancer; Suppression = autoimmune diseases"
        },
        {
          "answer": "Immunotherapy is the same as vaccination",
          "error": "Confusing prevention with treatment",
          "fix": "Vaccines prevent disease; immunotherapy treats existing disease",
          "action": "Vaccines = prevention; Immunotherapy = treatment"
        }
      ],
      "persistent": {
        "gap": "Confusion about immunotherapy types",
        "action": "Immunotherapy: activation (cancer) or suppression (autoimmune), modulates immune response"
      }
    },
    "monoclonal_antibodies": {
      "formula": "Monoclonal antibodies are identical antibodies produced from a single B cell clone targeting specific epitopes",
      "correct": "Hybridoma technology fuses plasma cells with immortal tumour cells to produce unlimited identical antibodies",
      "wrong": [
        {
          "answer": "Monoclonal antibodies are produced by mixing different antibodies",
          "error": "Confusing monoclonal with polyclonal",
          "fix": "Monoclonal = from one clone (identical); Polyclonal = from multiple clones (mixed)",
          "action": "Mono = one; Poly = many; Clonal = from same cell"
        },
        {
          "answer": "Monoclonal antibodies are made directly in patients",
          "error": "Misunderstanding production process",
          "fix": "Monoclonal antibodies are produced in laboratories using hybridoma cells",
          "action": "Lab production: antigen \u2192 mouse \u2192 plasma cells + tumour cells \u2192 hybridoma"
        },
        {
          "answer": "Monoclonal antibodies recognise multiple epitopes",
          "error": "Not understanding specificity",
          "fix": "Each monoclonal antibody recognises only one specific epitope",
          "action": "Monoclonal = one epitope; Polyclonal = multiple epitopes"
        }
      ],
      "persistent": {
        "gap": "Confusion about monoclonal antibody production and specificity",
        "action": "Monoclonal: one clone \u2192 one epitope \u2192 identical antibodies \u2192 specific targeting"
      }
    },
    "hybridoma_technology": {
      "formula": "Hybridoma cells are created by fusing antigen-specific plasma cells with immortal myeloma cells",
      "correct": "The hybridoma combines antibody production capability with unlimited cell division",
      "wrong": [
        {
          "answer": "Hybridomas are natural cells",
          "error": "Not recognising artificial creation",
          "fix": "Hybridomas are artificially created fusion cells, not natural",
          "action": "Hybridoma = hybrid (fusion) + oma (tumour-like) = artificial"
        },
        {
          "answer": "Any cell can be used to make hybridomas",
          "error": "Missing specific cell requirements",
          "fix": "Hybridomas require plasma cells (for antibody production) and myeloma cells (for immortality)",
          "action": "Plasma cell (antibody) + Myeloma (immortal) = Hybridoma"
        },
        {
          "answer": "Hybridomas can only make one batch of antibodies",
          "error": "Missing the immortal advantage",
          "fix": "Hybridomas are immortal and can produce unlimited quantities of antibodies",
          "action": "Immortal hybridoma = endless antibody production"
        }
      ],
      "persistent": {
        "gap": "Incomplete understanding of hybridoma creation",
        "action": "Process: immunise mouse \u2192 harvest plasma cells \u2192 fuse with myeloma \u2192 select hybridoma"
      }
    },
    "cancer_treatment": {
      "formula": "Monoclonal antibodies treat cancer by targeting tumour antigens, blocking checkpoints, or delivering drugs",
      "correct": "Cancer cells express neoantigens that can be targeted by specifically designed monoclonal antibodies",
      "wrong": [
        {
          "answer": "Cancer cells are always attacked by the immune system",
          "error": "Not understanding immune evasion",
          "fix": "Cancer cells often evade immunity; immunotherapy helps the immune system recognise them",
          "action": "Cancer evades immunity; immunotherapy overcomes evasion"
        },
        {
          "answer": "Monoclonal antibodies directly kill all cancer cells",
          "error": "Oversimplifying mechanisms",
          "fix": "Antibodies work through various mechanisms: opsonisation, checkpoint blocking, drug delivery",
          "action": "Mechanisms: marking for destruction, blocking inhibition, targeting drugs"
        },
        {
          "answer": "Cancer immunotherapy always works",
          "error": "Overestimating effectiveness",
          "fix": "Immunotherapy effectiveness varies; not all patients or cancers respond",
          "action": "Response varies by cancer type, patient factors, and tumour characteristics"
        }
      ],
      "persistent": {
        "gap": "Incomplete understanding of cancer immunotherapy mechanisms",
        "action": "Mechanisms: opsonisation, checkpoint inhibition, antibody-drug conjugates"
      }
    },
    "checkpoint_inhibitors": {
      "formula": "Checkpoint inhibitors block regulatory proteins that normally suppress T cell activity against cancer",
      "correct": "Blocking checkpoints like PD-1 or CTLA-4 releases the brakes on T cell anti-tumour responses",
      "wrong": [
        {
          "answer": "Checkpoint inhibitors suppress immunity",
          "error": "Reversing the mechanism",
          "fix": "Checkpoint inhibitors RELEASE suppression, allowing stronger immune responses",
          "action": "Inhibit the inhibitor = activate immunity"
        },
        {
          "answer": "Checkpoints are cancer proteins",
          "error": "Misunderstanding checkpoint origin",
          "fix": "Checkpoints are normal regulatory proteins; cancers exploit them to avoid immunity",
          "action": "Checkpoints = normal regulation; Cancer = exploits for evasion"
        },
        {
          "answer": "Checkpoint inhibitors have no side effects",
          "error": "Ignoring autoimmune risks",
          "fix": "Releasing immune suppression can cause autoimmune-like side effects",
          "action": "More immunity = risk of attacking healthy tissue"
        }
      ],
      "persistent": {
        "gap": "Confusion about checkpoint inhibitor mechanism",
        "action": "Checkpoints = brakes on immunity; Inhibitors = release brakes \u2192 stronger anti-cancer response"
      }
    },
    "autoimmune_diseases": {
      "formula": "Autoimmune diseases occur when the immune system attacks self-tissues due to loss of tolerance",
      "correct": "Antigenic mimicry by pathogens can trigger cross-reactive immune responses against host tissues",
      "wrong": [
        {
          "answer": "Autoimmune diseases are infections",
          "error": "Confusing autoimmunity with infection",
          "fix": "Autoimmune diseases involve immune attack on self; infections involve pathogens",
          "action": "Autoimmune = self-attack; Infection = pathogen attack"
        },
        {
          "answer": "Autoimmune diseases are always genetic",
          "error": "Oversimplifying causation",
          "fix": "Autoimmunity involves genetic predisposition plus environmental triggers",
          "action": "Causes: genetics + environment (infection, stress, etc.)"
        },
        {
          "answer": "Autoimmune diseases can be cured",
          "error": "Overestimating current treatments",
          "fix": "Most autoimmune diseases are managed, not cured; treatment reduces symptoms",
          "action": "Current treatment = management; Cure = not yet available for most"
        }
      ],
      "persistent": {
        "gap": "Misunderstanding autoimmune disease causation",
        "action": "Autoimmunity: loss of self-tolerance \u2192 immune attack on own tissues"
      }
    },
    "autoimmune_treatment": {
      "formula": "Monoclonal antibodies treat autoimmune diseases by targeting inflammatory mediators or immune cells",
      "correct": "Anti-TNF antibodies reduce inflammation in rheumatoid arthritis; anti-CD20 depletes B cells in some diseases",
      "wrong": [
        {
          "answer": "Autoimmune treatments activate immunity",
          "error": "Confusing with cancer treatment",
          "fix": "Autoimmune treatment SUPPRESSES harmful immune responses; cancer treatment activates them",
          "action": "Autoimmune = suppress; Cancer = activate"
        },
        {
          "answer": "One antibody treats all autoimmune diseases",
          "error": "Not recognising disease diversity",
          "fix": "Different autoimmune diseases require different targeted treatments",
          "action": "Specific targets for specific diseases"
        },
        {
          "answer": "Immunosuppression has no risks",
          "error": "Ignoring infection risk",
          "fix": "Suppressing immunity increases infection risk and requires monitoring",
          "action": "Less immunity = more infection risk"
        }
      ],
      "persistent": {
        "gap": "Incomplete understanding of autoimmune treatment",
        "action": "Treatment targets: TNF (inflammation), B cells (CD20), T cells, cytokines"
      }
    },
    "tnf_inhibitors": {
      "formula": "Anti-TNF antibodies block tumour necrosis factor, reducing inflammation in conditions like rheumatoid arthritis",
      "correct": "TNF is a pro-inflammatory cytokine; blocking it reduces joint damage and symptoms",
      "wrong": [
        {
          "answer": "TNF inhibitors cure rheumatoid arthritis",
          "error": "Overestimating treatment outcome",
          "fix": "TNF inhibitors manage symptoms and slow progression but don't cure the disease",
          "action": "Treatment = management; Not = cure"
        },
        {
          "answer": "TNF is only harmful",
          "error": "Not recognising TNF's normal role",
          "fix": "TNF has important roles in normal immunity; only excess TNF causes problems",
          "action": "Normal TNF = useful; Excess TNF = harmful inflammation"
        },
        {
          "answer": "TNF inhibitors are safe for everyone",
          "error": "Ignoring contraindications",
          "fix": "TNF inhibitors increase infection risk and are not suitable for patients with active infections",
          "action": "Contraindications: active infections, certain cancers, heart failure"
        }
      ],
      "persistent": {
        "gap": "Incomplete understanding of TNF and its inhibition",
        "action": "TNF = inflammatory cytokine; Anti-TNF = reduces inflammation but increases infection risk"
      }
    }
  },
  "content": {
    "round1": {
      "overview": {
        "title": "Immunotherapy Basics",
        "instructions": "Understand what immunotherapy is and its two main approaches.",
        "sentences": [
          {
            "text": "Immunotherapy treats diseases by {{d1}} the body's normal {{d2}} response.",
            "questions": {
              "d1": {
                "correct": "modulating",
                "distractors": [
                  "replacing",
                  "eliminating",
                  "ignoring"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What does immunotherapy do to immunity?"
              },
              "d2": {
                "correct": "immune",
                "distractors": [
                  "nervous",
                  "digestive",
                  "respiratory"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "Which body system is modulated?"
              }
            }
          },
          {
            "text": "{{d1}} immunotherapies enhance immune responses to fight cancer, while {{d2}} immunotherapies reduce harmful responses.",
            "questions": {
              "d1": {
                "correct": "Activation",
                "distractors": [
                  "Suppression",
                  "Prevention",
                  "Elimination"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What type of immunotherapy enhances responses?"
              },
              "d2": {
                "correct": "suppression",
                "distractors": [
                  "activation",
                  "enhancement",
                  "stimulation"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What type reduces immune responses?"
              }
            }
          },
          {
            "text": "Immunotherapy strategies include non-specific {{d1}} like cytokines and specific {{d2}} antibodies.",
            "questions": {
              "d1": {
                "correct": "immunomodulators",
                "distractors": [
                  "antibiotics",
                  "antivirals",
                  "painkillers"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What general immune-modulating substances are used?"
              },
              "d2": {
                "correct": "monoclonal",
                "distractors": [
                  "polyclonal",
                  "diverse",
                  "random"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What type of specific antibodies are used?"
              }
            }
          }
        ]
      },
      "antibodies": {
        "title": "Monoclonal Antibody Basics",
        "instructions": "Learn what monoclonal antibodies are and how they're made.",
        "sentences": [
          {
            "text": "Monoclonal antibodies are {{d1}} antibodies derived from a single {{d2}} cell clone.",
            "questions": {
              "d1": {
                "correct": "identical",
                "distractors": [
                  "different",
                  "random",
                  "mixed"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "How do monoclonal antibodies compare to each other?"
              },
              "d2": {
                "correct": "B",
                "distractors": [
                  "T",
                  "NK",
                  "mast"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "From what cell type are they derived?"
              }
            }
          },
          {
            "text": "To produce monoclonal antibodies, an animal is injected with an {{d1}} to produce antigen-specific {{d2}} cells.",
            "questions": {
              "d1": {
                "correct": "antigen",
                "distractors": [
                  "antibody",
                  "pathogen only",
                  "cytokine"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "What is injected to stimulate antibody production?"
              },
              "d2": {
                "correct": "plasma",
                "distractors": [
                  "red blood",
                  "nerve",
                  "muscle"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "What antibody-producing cells are harvested?"
              }
            }
          },
          {
            "text": "Plasma cells are fused with {{d1}} cells to create {{d2}} cells capable of unlimited antibody production.",
            "questions": {
              "d1": {
                "correct": "tumour",
                "distractors": [
                  "normal",
                  "dead",
                  "bacterial"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "What immortal cells are used for fusion?"
              },
              "d2": {
                "correct": "hybridoma",
                "distractors": [
                  "plasma",
                  "memory",
                  "effector"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "What are the fusion cells called?"
              }
            }
          }
        ]
      },
      "cancer": {
        "title": "Cancer Treatment Basics",
        "instructions": "Learn how immunotherapy treats cancer.",
        "sentences": [
          {
            "text": "Cancer cells produce novel proteins called {{d1}} that can be targeted by {{d2}} antibodies.",
            "questions": {
              "d1": {
                "correct": "neoantigens",
                "distractors": [
                  "self-antigens",
                  "normal proteins",
                  "cytokines"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What unique proteins do cancer cells produce?"
              },
              "d2": {
                "correct": "monoclonal",
                "distractors": [
                  "polyclonal",
                  "natural",
                  "maternal"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What type of antibodies target neoantigens?"
              }
            }
          },
          {
            "text": "Cancer cells often evade immune detection, so immunotherapy helps the immune system {{d1}} and {{d2}} them.",
            "questions": {
              "d1": {
                "correct": "recognise",
                "distractors": [
                  "ignore",
                  "protect",
                  "feed"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What does immunotherapy help immunity do?"
              },
              "d2": {
                "correct": "destroy",
                "distractors": [
                  "protect",
                  "nourish",
                  "multiply"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What is the goal for cancer cells?"
              }
            }
          },
          {
            "text": "Antibodies can mark cancer cells for destruction through {{d1}}, enhancing {{d2}} by phagocytes.",
            "questions": {
              "d1": {
                "correct": "opsonisation",
                "distractors": [
                  "neutralisation",
                  "agglutination",
                  "precipitation"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What is antibody coating called?"
              },
              "d2": {
                "correct": "phagocytosis",
                "distractors": [
                  "exocytosis",
                  "apoptosis",
                  "mitosis"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What process destroys opsonised cells?"
              }
            }
          }
        ]
      },
      "autoimmune": {
        "title": "Autoimmune Disease Basics",
        "instructions": "Learn about autoimmunity and its treatment.",
        "sentences": [
          {
            "text": "{{d1}} occurs when the immune system fails to recognise body cells as {{d2}} and attacks them.",
            "questions": {
              "d1": {
                "correct": "Autoimmunity",
                "distractors": [
                  "Immunity",
                  "Allergy",
                  "Infection"
                ],
                "concept": "autoimmune_diseases",
                "tooltip": "What is immune attack on self-tissues called?"
              },
              "d2": {
                "correct": "self",
                "distractors": [
                  "foreign",
                  "pathogenic",
                  "dangerous"
                ],
                "concept": "autoimmune_diseases",
                "tooltip": "What recognition is lost in autoimmunity?"
              }
            }
          },
          {
            "text": "Some pathogens produce antigens that closely resemble host markers, a phenomenon called antigenic {{d1}}, leading to {{d2}} reactivity.",
            "questions": {
              "d1": {
                "correct": "mimicry",
                "distractors": [
                  "variation",
                  "drift",
                  "shift"
                ],
                "concept": "autoimmune_diseases",
                "tooltip": "What is pathogen resemblance to self called?"
              },
              "d2": {
                "correct": "cross",
                "distractors": [
                  "no",
                  "specific",
                  "targeted"
                ],
                "concept": "autoimmune_diseases",
                "tooltip": "What type of reactivity results from mimicry?"
              }
            }
          },
          {
            "text": "Monoclonal antibodies treat autoimmune diseases by targeting {{d1}} proteins and reducing {{d2}}.",
            "questions": {
              "d1": {
                "correct": "pro-inflammatory",
                "distractors": [
                  "anti-inflammatory",
                  "protective",
                  "healing"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What type of proteins are targeted?"
              },
              "d2": {
                "correct": "inflammation",
                "distractors": [
                  "immunity",
                  "healing",
                  "protection"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What is reduced by treatment?"
              }
            }
          }
        ]
      }
    },
    "round2": {
      "overview": {
        "title": "Immunotherapy Approaches",
        "instructions": "Understand how different immunotherapies work.",
        "sentences": [
          {
            "text": "Activation immunotherapy for cancer aims to {{d1}} immune responses that have been suppressed by {{d2}} cells.",
            "questions": {
              "d1": {
                "correct": "restore",
                "distractors": [
                  "suppress",
                  "eliminate",
                  "ignore"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What does activation immunotherapy do to responses?"
              },
              "d2": {
                "correct": "tumour",
                "distractors": [
                  "immune",
                  "blood",
                  "nerve"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What cells suppress immunity?"
              }
            }
          },
          {
            "text": "Suppression immunotherapy for autoimmune diseases aims to {{d1}} overactive immune responses that damage {{d2}} tissues.",
            "questions": {
              "d1": {
                "correct": "reduce",
                "distractors": [
                  "increase",
                  "enhance",
                  "stimulate"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What does suppression immunotherapy do?"
              },
              "d2": {
                "correct": "healthy",
                "distractors": [
                  "foreign",
                  "pathogenic",
                  "cancerous"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What tissues are protected?"
              }
            }
          },
          {
            "text": "The choice between activation and suppression depends on whether the immune response is {{d1}} (autoimmune) or {{d2}} (cancer).",
            "questions": {
              "d1": {
                "correct": "excessive",
                "distractors": [
                  "insufficient",
                  "normal",
                  "absent"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "How is immunity characterised in autoimmunity?"
              },
              "d2": {
                "correct": "insufficient",
                "distractors": [
                  "excessive",
                  "normal",
                  "overactive"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "How is immunity characterised in cancer?"
              }
            }
          }
        ]
      },
      "antibodies": {
        "title": "Hybridoma Production",
        "instructions": "Understand the process of making monoclonal antibodies.",
        "sentences": [
          {
            "text": "The hybridoma cell combines the antibody {{d1}} capability of plasma cells with the {{d2}} division of myeloma cells.",
            "questions": {
              "d1": {
                "correct": "production",
                "distractors": [
                  "recognition",
                  "binding",
                  "neutralisation"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "What capability comes from plasma cells?"
              },
              "d2": {
                "correct": "unlimited",
                "distractors": [
                  "limited",
                  "controlled",
                  "regulated"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "What division capability comes from myeloma cells?"
              }
            }
          },
          {
            "text": "Hybridomas can be cultured {{d1}} to produce large quantities of {{d2}} monoclonal antibodies.",
            "questions": {
              "d1": {
                "correct": "indefinitely",
                "distractors": [
                  "once",
                  "briefly",
                  "rarely"
                ],
                "concept": "hybridoma_technology",
                "tooltip": "How long can hybridomas be cultured?"
              },
              "d2": {
                "correct": "identical",
                "distractors": [
                  "different",
                  "random",
                  "varied"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What is the relationship between antibodies produced?"
              }
            }
          },
          {
            "text": "Each monoclonal antibody is specific to one {{d1}}, the part of the antigen that antibodies {{d2}}.",
            "questions": {
              "d1": {
                "correct": "epitope",
                "distractors": [
                  "pathogen",
                  "cell",
                  "tissue"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What specific antigen region is recognised?"
              },
              "d2": {
                "correct": "bind",
                "distractors": [
                  "avoid",
                  "destroy",
                  "create"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What do antibodies do to epitopes?"
              }
            }
          }
        ]
      },
      "cancer": {
        "title": "Cancer Immunotherapy Mechanisms",
        "instructions": "Understand different mechanisms of cancer immunotherapy.",
        "sentences": [
          {
            "text": "{{d1}} inhibitors block regulatory proteins that normally {{d2}} T cell activity against tumours.",
            "questions": {
              "d1": {
                "correct": "Checkpoint",
                "distractors": [
                  "Activation",
                  "Stimulation",
                  "Enhancement"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What type of inhibitors release immune brakes?"
              },
              "d2": {
                "correct": "suppress",
                "distractors": [
                  "enhance",
                  "activate",
                  "stimulate"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What do checkpoints normally do to T cells?"
              }
            }
          },
          {
            "text": "Blocking PD-1 or CTLA-4 {{d1}} the brakes on T cell responses, allowing stronger {{d2}} immunity.",
            "questions": {
              "d1": {
                "correct": "releases",
                "distractors": [
                  "applies",
                  "strengthens",
                  "maintains"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What happens when checkpoints are blocked?"
              },
              "d2": {
                "correct": "anti-tumour",
                "distractors": [
                  "pro-tumour",
                  "autoimmune",
                  "allergic"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What type of immunity is enhanced?"
              }
            }
          },
          {
            "text": "Antibody-drug {{d1}} combine antibody specificity with cytotoxic drugs to target {{d2}} cells specifically.",
            "questions": {
              "d1": {
                "correct": "conjugates",
                "distractors": [
                  "mixtures",
                  "solutions",
                  "vaccines"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What are antibody-drug combinations called?"
              },
              "d2": {
                "correct": "cancer",
                "distractors": [
                  "normal",
                  "healthy",
                  "all"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What cells are targeted specifically?"
              }
            }
          }
        ]
      },
      "autoimmune": {
        "title": "Autoimmune Treatment Mechanisms",
        "instructions": "Understand how autoimmune diseases are treated with immunotherapy.",
        "sentences": [
          {
            "text": "{{d1}} (tumour necrosis factor) is a key mediator of inflammatory responses that causes joint {{d2}} in rheumatoid arthritis.",
            "questions": {
              "d1": {
                "correct": "TNF",
                "distractors": [
                  "IgG",
                  "CD4",
                  "MHC"
                ],
                "concept": "tnf_inhibitors",
                "tooltip": "What cytokine is a major inflammatory mediator?"
              },
              "d2": {
                "correct": "damage",
                "distractors": [
                  "healing",
                  "growth",
                  "strengthening"
                ],
                "concept": "tnf_inhibitors",
                "tooltip": "What does TNF cause in joints?"
              }
            }
          },
          {
            "text": "Anti-TNF antibodies {{d1}} TNF, reducing the {{d2}} that damages joints and tissues.",
            "questions": {
              "d1": {
                "correct": "block",
                "distractors": [
                  "enhance",
                  "increase",
                  "stimulate"
                ],
                "concept": "tnf_inhibitors",
                "tooltip": "What do anti-TNF antibodies do?"
              },
              "d2": {
                "correct": "inflammation",
                "distractors": [
                  "immunity",
                  "healing",
                  "protection"
                ],
                "concept": "tnf_inhibitors",
                "tooltip": "What is reduced by blocking TNF?"
              }
            }
          },
          {
            "text": "Some autoimmune treatments target B cell surface protein {{d1}}, depleting {{d2}} cells that produce harmful antibodies.",
            "questions": {
              "d1": {
                "correct": "CD20",
                "distractors": [
                  "CD4",
                  "CD8",
                  "CD3"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What B cell marker is targeted?"
              },
              "d2": {
                "correct": "B",
                "distractors": [
                  "T",
                  "NK",
                  "mast"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What cells are depleted?"
              }
            }
          }
        ]
      }
    },
    "round3": {
      "overview": {
        "title": "Clinical Considerations",
        "instructions": "Understand clinical applications and limitations of immunotherapy.",
        "sentences": [
          {
            "text": "Immunotherapy has transformed {{d1}} treatment but requires careful patient {{d2}} for optimal outcomes.",
            "questions": {
              "d1": {
                "correct": "cancer",
                "distractors": [
                  "infection",
                  "allergy",
                  "injury"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What disease has immunotherapy transformed?"
              },
              "d2": {
                "correct": "selection",
                "distractors": [
                  "rejection",
                  "isolation",
                  "exclusion"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What is needed for optimal outcomes?"
              }
            }
          },
          {
            "text": "Combination immunotherapies using multiple {{d1}} may be more effective but also increase {{d2}} effects.",
            "questions": {
              "d1": {
                "correct": "agents",
                "distractors": [
                  "patients",
                  "hospitals",
                  "countries"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What is combined in combination therapy?"
              },
              "d2": {
                "correct": "side",
                "distractors": [
                  "therapeutic",
                  "healing",
                  "beneficial"
                ],
                "concept": "immunotherapy_overview",
                "tooltip": "What unwanted effects may increase?"
              }
            }
          },
          {
            "text": "Personalised immunotherapy approaches use patient {{d1}} profiles to select the most appropriate {{d2}}.",
            "questions": {
              "d1": {
                "correct": "tumour",
                "distractors": [
                  "personality",
                  "financial",
                  "social"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What profiles guide treatment selection?"
              },
              "d2": {
                "correct": "treatment",
                "distractors": [
                  "hospital",
                  "doctor",
                  "schedule"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What is selected based on profiles?"
              }
            }
          }
        ]
      },
      "antibodies": {
        "title": "Antibody Engineering",
        "instructions": "Understand advances in monoclonal antibody technology.",
        "sentences": [
          {
            "text": "{{d1}} antibodies combine mouse variable regions with human constant regions to reduce {{d2}} reactions.",
            "questions": {
              "d1": {
                "correct": "Chimeric",
                "distractors": [
                  "Murine",
                  "Human",
                  "Polyclonal"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What are mixed mouse-human antibodies called?"
              },
              "d2": {
                "correct": "immune",
                "distractors": [
                  "therapeutic",
                  "beneficial",
                  "healing"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What reactions are reduced?"
              }
            }
          },
          {
            "text": "Fully {{d1}} antibodies are now produced using transgenic mice or phage display, improving {{d2}}.",
            "questions": {
              "d1": {
                "correct": "human",
                "distractors": [
                  "mouse",
                  "bacterial",
                  "viral"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What type of antibodies reduce immune reactions?"
              },
              "d2": {
                "correct": "tolerability",
                "distractors": [
                  "effectiveness only",
                  "cost",
                  "speed"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "What patient factor is improved?"
              }
            }
          },
          {
            "text": "Bispecific antibodies can bind {{d1}} different targets simultaneously, bringing immune cells to {{d2}}.",
            "questions": {
              "d1": {
                "correct": "two",
                "distractors": [
                  "one",
                  "ten",
                  "hundred"
                ],
                "concept": "monoclonal_antibodies",
                "tooltip": "How many targets can bispecific antibodies bind?"
              },
              "d2": {
                "correct": "tumours",
                "distractors": [
                  "healthy tissue",
                  "blood",
                  "bone"
                ],
                "concept": "cancer_treatment",
                "tooltip": "Where do bispecific antibodies direct immune cells?"
              }
            }
          }
        ]
      },
      "cancer": {
        "title": "Cancer Immunotherapy Challenges",
        "instructions": "Understand challenges and side effects of cancer immunotherapy.",
        "sentences": [
          {
            "text": "Checkpoint inhibitors can cause {{d1}} side effects as released T cells attack {{d2}} tissues.",
            "questions": {
              "d1": {
                "correct": "autoimmune-like",
                "distractors": [
                  "allergic",
                  "infectious",
                  "cancerous"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What type of side effects can occur?"
              },
              "d2": {
                "correct": "healthy",
                "distractors": [
                  "tumour only",
                  "pathogen",
                  "foreign"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What tissues may be attacked?"
              }
            }
          },
          {
            "text": "Not all patients respond to immunotherapy, and some tumours develop {{d1}} through various {{d2}} mechanisms.",
            "questions": {
              "d1": {
                "correct": "resistance",
                "distractors": [
                  "sensitivity",
                  "vulnerability",
                  "susceptibility"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What do some tumours develop?"
              },
              "d2": {
                "correct": "escape",
                "distractors": [
                  "attraction",
                  "sensitivity",
                  "exposure"
                ],
                "concept": "cancer_treatment",
                "tooltip": "What mechanisms cause resistance?"
              }
            }
          },
          {
            "text": "Biomarkers like {{d1}} expression help predict which patients will {{d2}} to checkpoint inhibitors.",
            "questions": {
              "d1": {
                "correct": "PD-L1",
                "distractors": [
                  "CD4",
                  "IgG",
                  "TNF"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What marker predicts checkpoint inhibitor response?"
              },
              "d2": {
                "correct": "respond",
                "distractors": [
                  "resist",
                  "reject",
                  "ignore"
                ],
                "concept": "checkpoint_inhibitors",
                "tooltip": "What do biomarkers help predict?"
              }
            }
          }
        ]
      },
      "autoimmune": {
        "title": "Managing Autoimmune Treatment",
        "instructions": "Understand the balance of autoimmune treatment.",
        "sentences": [
          {
            "text": "Long-term immunosuppression increases {{d1}} risk, requiring regular {{d2}} and preventive measures.",
            "questions": {
              "d1": {
                "correct": "infection",
                "distractors": [
                  "autoimmunity",
                  "allergy",
                  "cancer only"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What risk increases with immunosuppression?"
              },
              "d2": {
                "correct": "monitoring",
                "distractors": [
                  "ignoring",
                  "stopping",
                  "increasing"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What is required during treatment?"
              }
            }
          },
          {
            "text": "Treatment aims to {{d1}} disease activity while minimising side effects, finding the optimal {{d2}}.",
            "questions": {
              "d1": {
                "correct": "control",
                "distractors": [
                  "increase",
                  "ignore",
                  "spread"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What is the goal for disease activity?"
              },
              "d2": {
                "correct": "balance",
                "distractors": [
                  "dose only",
                  "schedule",
                  "cost"
                ],
                "concept": "autoimmune_treatment",
                "tooltip": "What must be found between benefit and risk?"
              }
            }
          },
          {
            "text": "{{d1}} rheumatoid arthritis patients are now an example of how targeted immunotherapy improves quality of {{d2}}.",
            "questions": {
              "d1": {
                "correct": "Many",
                "distractors": [
                  "No",
                  "Few",
                  "All cured"
                ],
                "concept": "tnf_inhibitors",
                "tooltip": "How many RA patients benefit from anti-TNF?"
              },
              "d2": {
                "correct": "life",
                "distractors": [
                  "antibodies",
                  "treatment",
                  "drugs"
                ],
                "concept": "tnf_inhibitors",
                "tooltip": "What outcome is improved?"
              }
            }
          }
        ]
      }
    }
  }
}